Found 4 results
Filters: Author is S. Honsawek  [Clear All Filters]
S. Malila, Yuktanandana, P., Saowaprut, S., Jiamjarasrangsi, W., and Honsawek, S., Association between matrix metalloproteinase-3 polymorphism and anterior cruciate ligament ruptures, vol. 10, pp. 4158-4165, 2011.
Astolfi CM, Shinohara AL, da Silva RA, Santos MC, et al. (2006). Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J. Clin. Periodontol. 33: 699-703. PMid:16899023   Brooks JH, Fuller CW, Kemp SP and Reddin DB (2005). Epidemiology of injuries in English professional rugby union: part 1 match injuries. Br. J. Sports Med. 39: 757-766. PMid:16183774 PMCid:1725032   Chakraborti S, Mandal M, Das S, Mandal A, et al. (2003). Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253: 269-285. PMid:14619979   Collins M and Raleigh SM (2009). Genetic risk factors for musculoskeletal soft tissue injuries. Med. Sport Sci. 54: 136- 149. PMid:19696512   de Loes M, Dahlstedt LJ and Thomee R (2000). A 7-year study on risks and costs of knee injuries in male and female youth participants in 12 sports. Scand. J. Med. Sci. Sports 10: 90-97. PMid:10755279   Deacon A, Bennell K, Kiss ZS, Crossley K, et al. (1997). Osteoarthritis of the knee in retired, elite Australian rules footballers. Med. J. Aust. 166: 187-190. PMid:9066547   Dunleavey L, Beyzade S and Ye S (2000). Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 151: 587-589.   Duthon VB, Barea C, Abrassart S, Fasel JH, et al. (2006). Anatomy of the anterior cruciate ligament. Knee Surg. Sports Traumatol. Arthrosc. 14: 204-213. PMid:16235056   Flynn RK, Pedersen CL, Birmingham TB, Kirkley A, et al. (2005). The familial predisposition toward tearing the anterior cruciate ligament: a case control study. Am. J. Sports Med. 33: 23-28. PMid:15610995   Higuchi H, Shirakura K, Kimura M, Terauchi M, et al. (2006). Changes in biochemical parameters after anterior cruciate ligament injury. Int. Orthop. 30: 43-47. PMid:16333657 PMCid:2254663   Liu Z, Tang NL, Cao XB, Liu WJ, et al. (2010). Lack of association between the promoter polymorphisms of MMP-3 and IL-6 genes and adolescent idiopathic scoliosis: a case-control study in a Chinese Han population. Spine 35: 1701- 1705. PMid:20436380   Lu Z, Cao Y, Wang Y, Zhang Q, et al. (2007). Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J. Neurooncol. 85: 65-73. PMid:17502998   Marshall SW, Padua D and McGrath M (2007). Incidence of ACL injuries. Hum. Kinet. 5-30.   Matrisian LM (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6: 121-125.   Mattey DL, Nixon NB, Dawes PT, Ollier WE, et al. (2004). Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun. 5: 147-149. PMid:14712311   Nagase H, Visse R and Murphy G (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69: 562-573. PMid:16405877   Posthumus M, September AV, Keegan M, O'Cuinneagain D, et al. (2009). Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant. Br. J. Sports Med. 43: 352-356. PMid:19193663   Samnegard A, Silveira A, Lundman P, Boquist S, et al. (2005). Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J. Intern. Med. 258: 411-419. PMid:16238676   Stevens KJ and Dragoo JL (2006). Anterior cruciate ligament tears and associated injuries. Top. Magn. Reson. Imaging 17: 347-362. PMid:17414996   Takahashi M, Haro H, Wakabayashi Y, Kawauchi T, et al. (2001). The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J. Bone Joint Surg. Br. 83: 491-495. PMid:11380116   Ye S (2000). Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 19: 623-629.   Yougu H (2004). Hernia of intervertebral discs in Chinese. People's Medical Publishing House.   Yuan HY, Tang Y, Liang YX, Lei L, et al. (2010). Matrix metalloproteinase-3 and vitamin d receptor genetic polymorphisms, and their interactions with occupational exposure in lumbar disc degeneration. J. Occup. Health 52: 23-30. PMid:20009418
S. Honsawek, Deepaisarnsakul, B., Tanavalee, A., Yuktanandana, P., Bumrungpanichthaworn, P., Malila, S., and Saetan, N., Association of the IL-6 -174G/C gene polymorphism with knee osteoarthritis in a Thai population, vol. 10, pp. 1674-1680, 2011.
Banks SE (2010). Erosive osteoarthritis: a current review of a clinical challenge. Clin. Rheumatol. 29: 697-706. PMid:20108014 Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, et al. (1988). The human “interferon-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3: 8-16. Fernández-Real JM, Broch M, Vendrell J, Richart C, et al. (2000). Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J. Clin. Endocrinol. Metab. 85: 1334-1339. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102: 1369-1376. PMid:9769329    PMCid:508984 Goldring SR and Goldring MB (2004). The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. S27-S36. PMid:15480070 Ishihara K and Hirano T (2002). IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13: 357-368. Jikko A, Wakisaka T, Iwamoto M, Hiranuma H, et al. (1998). Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biol. Int. 22: 615-621. PMid:10452831 Kämäräinen OP, Solovieva S, Vehmas T, Luoma K, et al. (2008). Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res. Ther. 10: R21. Kaneko S, Satoh T, Chiba J, Ju C, et al. (2000). Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol. Ther. 6: 71-79. Kellgren JH and Lawrence JS (1957). Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 16: 494-502. PMid:13498604    PMCid:1006995 Krasnokutsky S, Attur M, Palmer G, Samuels J, et al. (2008). Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 16 (Suppl 3): S1-S3. PMid:18723377 Krenn V, Hensel F, Kim HJ, Souto Carneiro MM, et al. (1999). Molecular IgV(H) analysis demonstrates highly somatic mutated B cells in synovialitis of osteoarthritis: a degenerative disease is associated with a specific, not locally generated immune response. Lab. Invest. 79: 1377-1384. PMid:10576208 Loeser RF (2009). Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 17: 971-979. PMid:19303469    PMCid:2713363 Mohtai M, Gupta MK, Donlon B, Ellison B, et al. (1996). Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. J. Orthop. Res. 14: 67-73. PMid:8618168 Pola E, Papaleo P, Pola R, Gaetani E, et al. (2005). Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study. Osteoarthritis Cartilage 13: 1025-1028. PMid:16198603 Steinmeyer J (2004). Cytokines in osteoarthritis-current status on the pharmacological intervention. Front. Biosci. 9: 575-580. PMid:14766392 Valdes AM, Loughlin J, Oene MV, Chapman K, et al. (2007). Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum. 56: 137-146.
S. Honsawek, Bumrungpanichthaworn, P., Thitiset, T., and Wolfinbarger, Jr., L., Gene expression analysis of demineralized bone matrix-induced osteogenesis in human periosteal cells using cDNA array technology, vol. 10, pp. 2093-2103, 2011.
Beck GR Jr, Zerler B and Moran E (2001). Gene array analysis of osteoblast differentiation. Cell Growth Differ. 12: 61-83. PMid:11243467 Boskey AL, Spevak L, Doty SB and Rosenberg L (1997). Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif. Tissue Int. 61: 298-305. PMid:9312200 Chen WB, Lenschow W, Tiede K, Fischer JW, et al. (2002). Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J. Biol. Chem. 277: 36118-36128. PMid:12140283 Ducy P, Schinke T and Karsenty G (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504. PMid:10968779 Honsawek S, Powers RM and Wolfinbarger L (2005). Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model. Cell Tissue Bank. 6: 13-23. PMid:15735897 Honsawek S, Dhitiseith D and Phupong V (2006). Effects of demineralized bone matrix on proliferation and osteogenic differentiation of mesenchymal stem cells from human umbilical cord. J. Med. Assoc. Thai. 89 (Suppl 3): S189-S195. PMid:17718287 Honsawek S, Dhitiseith D and Phupong V (2007). Gene expression characteristics of osteoblast differentiation in human umbilical cord mesenchymal stem cells induced by demineralized bone matrix. Asian Biomed. 1: 383-391. Honsawek S, Bumrungpanichthaworn P and Thanakit V (2010). Osteoinductive potential of small intestinal submucosa/ demineralized bone matrix as composite scaffolds for bone tissue engineering. Asian Biomed. 4: 913-922. Hutmacher DW and Sittinger M (2003). Periosteal cells in bone tissue engineering. Tissue Eng. 9 (Suppl 1): S45-S64. PMid:14511470 Locklin RM, Riggs BL, Hicok KC, Horton HF, et al. (2001). Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J. Bone Miner. Res. 16: 2192-2204. PMid:11760832 Meirowitz NB, Smulian JC, Hahn RA, Zhou P, et al. (2002). Collagen messenger RNA expression in the human amniochorion in premature rupture of membranes. Am. J. Obstet. Gynecol. 187: 1679-1685. PMid:12501083 Schena M, Shalon D, Heller R, Chai A, et al. (1996). Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. U. S. A. 93: 10614-10619. Walchli C, Koch M, Chiquet M, Odermatt BF, et al. (1994). Tissue-specific expression of the fibril-associated collagens XII and XIV. J. Cell Sci. 107: 669-681. PMid:8207089 Wolfinbarger L Jr and Zheng Y (1993). An in vitro bioassay to assess biological activity in demineralized bone. In Vitro Cell Dev. Biol. Anim. 29A: 914-916. Xu T, Bianco P, Fisher LW, Longenecker G, et al. (1998). Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20: 78-82. PMid:9771711 Zhang M, Powers RM Jr and Wolfinbarger L Jr (1997). A quantitative assessment of osteoinductivity of human demineralized bone matrix. J. Periodontol. 68: 1076-1084. PMid:9407400